---

$0.56

-0.0189 ( -3.25% ) 31.0K

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-09-21	Buy	600.00	PHILIPS CRAIG W.
2023-09-21	Buy	1500.00	Kenny Pauline
2023-09-21	Buy	10000.00	Iadonato Shawn
2023-09-19	Buy	5000.00	Baker Keith
2023-09-19	Buy	500.00	Bartoszek Raymond J.
2023-09-15	Buy	10000.00	Guillaudeux Thierry